TytoCare

Israeli telehealth startup TytoCare is laying off approximately 35 employees, representing about 20% of its 160-person workforce, as part of a restructuring announced in July 2025. This marks the company's second round of layoffs since 2023. The move aims to streamline operations and redirect investment toward advancing its FDA-approved, AI-driven diagnostic capabilities. Concurrently, CEO and co-founder Dedi Gilad will transition to the chairman role, focusing on long-term strategy, while co-founder Ofer Tzadik will oversee daily operations. The company, which has raised $205 million, is also adjusting its sales model to focus its home-use product in the U.S. via partners.

Israeli telehealth startup TytoCare laid off 20 employees, representing about 10% of its total workforce of 200 people, in July 2023. The company, which develops a digital device for remote medical testing and diagnosis, cited significant changes in the financial markets as the reason for the personnel adjustments. Approximately half of the affected employees were based in Israel, where the company employs 135 staff. Founded in 2012 and having raised $155 million in total funding, TytoCare stated it remains committed to advancing digital home medicine and expanding its global customer base despite the layoffs.